RG
Redmile Group Portfolio holdings
AUM
$940M
This Quarter Return
+16.66%
1 Year Return
+75.78%
3 Year Return
+543.67%
5 Year Return
+585.96%
10 Year Return
+6,653.82%
AUM
$838M
AUM Growth
+$838M
(+5.2%)
Cap. Flow
-$80.4M
Cap. Flow
% of AUM
-9.6%
Top 10 Holdings %
Top 10 Hldgs %
41.9%
Holding
74
New
19
Increased
15
Reduced
20
Closed
19
Top Buys
| 1 |
Agilent Technologies
A
|
$43.2M |
| 2 |
Bausch Health
BHC
|
$39.2M |
| 3 |
RAD
Rite Aid Corporation
RAD
|
$23.8M |
| 4 |
HCA Healthcare
HCA
|
$23.8M |
| 5 |
Prothena Corp
PRTA
|
$21.1M |
Top Sells
| 1 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$70.9M |
| 2 |
Gilead Sciences
GILD
|
$48.6M |
| 3 |
Zimmer Biomet
ZBH
|
$34.3M |
| 4 |
CELG
Celgene Corp
CELG
|
$30.9M |
| 5 |
AstraZeneca
AZN
|
$30.3M |
Sector Composition
| 1 | Healthcare | 80.49% |
| 2 | Technology | 2.82% |
| 3 | Communication Services | 1.03% |
| 4 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Align Technology
ALGN
$10.3B
| $15.3M | 1.82% | +294,612 | New | +$15.3M |
|
27
Accuray
ARAY
$157M
| $14.2M | 1.69% | 1,475,360 -269,451 | -15% | -$2.59M |
|
|
NXTM
28
DELISTED
NxStage Medical Inc.
NXTM
| $13.9M | 1.66% | 1,090,428 +399,658 | +58% | +$5.09M |
|
|
RCPT
29
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| $13M | 1.56% | 310,727 -314,406 | -50% | -$13.2M |
|
|
OXFD
30
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $12.5M | 1.5% | 624,869 -321,588 | -34% | -$6.45M |
|
|
CSII
31
DELISTED
Cardiovascular Systems, Inc.
CSII
| $12.5M | 1.49% | +391,627 | New | +$12.5M |
|
|
PTLA
32
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $11.7M | 1.4% | +452,194 | New | +$11.7M |
|
|
NSTG
33
DELISTED
NanoString Technologies, Inc.
NSTG
| $10.9M | 1.3% | 528,070 -226,590 | -30% | -$4.68M |
|
|
ELGX
34
DELISTED
Endologix Inc
ELGX
| $10.2M | 1.22% | 795,095 +479,362 | +152% | +$6.17M |
|
|
AKAO
35
DELISTED
Achaogen, Inc.
AKAO
| $10.1M | 1.21% | +653,700 | New | +$10.1M |
|
|
MODN
36
DELISTED
MODEL N, INC.
MODN
| $8.64M | 1.03% | 854,378 +763,071 | +836% | +$7.71M |
|
|
FLXN
37
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $8.11M | 0.97% | +493,183 | New | +$8.11M |
|
38
Xoma
XOMA
$392M
| $7.93M | 0.95% | 1,522,543 +741,367 | +95% | +$3.86M |
|
39
Inogen
INGN
$216M
| $7.61M | 0.91% | +460,923 | New | +$7.61M |
|
|
DSCI
40
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $7.58M | 0.91% | +598,077 | New | +$7.58M |
|
|
BSTC
41
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $7.04M | 0.84% | 271,620 -14,437 | -5% | -$374K |
|
|
RXDX
42
DELISTED
Ignyta, Inc.
RXDX
| $4.98M | 0.59% | +600,000 | New | +$4.98M |
|
43
Geron
GERN
$893M
| $4.41M | 0.53% | +2,117,555 | New | +$4.4M |
|
|
AMBI
44
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $3.35M | 0.4% | 367,602 -178,383 | -33% | -$1.63M |
|
|
VCRA
45
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
| $2.83M | 0.34% | 173,408 -110,992 | -39% | -$1.81M |
|
46
Cerus
CERS
$251M
| $2.81M | 0.34% | 586,205 -1,469,369 | -71% | -$7.05M |
|
|
GNCA
47
DELISTED
Genocea Biosciences, Inc.
GNCA
| $2.28M | 0.27% | +125,244 | New | +$2.28M |
|
48
Halozyme
HALO
$8.56B
| $815K | 0.1% | +64,167 | New | +$815K |
|
|
ISEE
49
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $692K | 0.08% | 19,374 -297,147 | -94% | -$10.6M |
|
|
CYNO
50
DELISTED
Cynosure, Inc. Class A
CYNO
| $586K | 0.07% | +20,000 | New | +$586K |
|